Skip to main content
. 2011 Mar 31;20(1):1–17. doi: 10.5607/en.2011.20.1.1

Table 2.

Nueroprotection in Parkinson's disease by selegline (prospective, randomized, double-blind, placebo-controlled studies)

graphic file with name en-20-1-i002.jpg

From Riederer and Lachenmayer 2003.